Astria Therapeutics, Inc. (ATXS)

Astria Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	615	279	251	70	43	70
Market Cap Growth	107.61%	11.26%	257.29%	63.15%	-38.35%	124.59%
Enterprise Value	245	33	25	-55	-1	36
PE Ratio	-	-3.82	-4.83	-0.32	-1.15	-2.65
PB Ratio	1.67	1.15	1.13	0.57	1.06	1.95
P/FCF Ratio	-10.40	-4.07	-5.74	-2.32	-1.32	-2.62
P/OCF Ratio	-10.40	-4.07	-5.76	-2.33	-1.32	-2.62
EV/EBITDA Ratio	-4.94	-0.45	-0.48	0.28	0.02	-1.36
EV/EBIT Ratio	-4.94	-0.45	-0.48	0.28	0.02	-1.36
EV/FCF Ratio	-5.42	-0.48	-0.57	1.82	0.03	-1.34
Debt / Equity Ratio	0.00	0.00	0.00	0.00	0.03	0.06
Debt / EBITDA Ratio	0.00	0.00	-0.02	0.00	-0.03	-0.09
Debt / FCF Ratio	0.00	0.00	-0.02	-0.01	-0.03	-0.08
Quick Ratio	33.41	21.34	24.99	24.12	7.03	7.20
Current Ratio	33.83	21.73	25.13	24.42	7.25	7.74
Return on Equity (ROE)	-32.80%	-34.70%	-38.20%	-304.10%	-76.70%	-62.90%
Return on Assets (ROA)	-31.60%	-33.40%	-36.30%	-158.90%	-67.60%	-55.80%
Return on Capital (ROIC)	-25.47%	-34.11%	-24.08%	-158.94%	-89.74%	-71.33%
Earnings Yield	-13.27%	-26.15%	-20.69%	-312.81%	-86.78%	-37.71%
FCF Yield	-12.08%	-24.56%	-17.41%	-43.03%	-75.66%	-38.12%
Buyback Yield / Dilution	-87.14%	-106.03%	-63.81%	-191.81%	-63.87%	-121.55%
Total Shareholder Return	-87.14%	-106.03%	-63.81%	-191.81%	-63.87%	-121.55%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).